Biosimulation is the mathematical simulation of complex, large biological processes on a computer. Biosimulation is being adopted at a faster pace, to extract and interpret vital data from experiments during drug discovery and development.
The report analyzes and presents an overview of Biosimulation market worldwide. The report provides global market estimates and projections for Biosimulation in US dollars for the years 2012 through 2017. Supported with 1 market data table, the report highlights the ever increasing permanence of Biosimulation. The report also provides a review of Biosimulation Models, and Biosimulation software. In addition, 36 companies operating in the Dye Sensitized Cells arena worldwide including Accelrys Inc., Entelos Inc., Rhenovia Pharma SAS and others are profiled.
Please note: Reports are sold as single-site single-user licenses. The delivery time for hard copies is between 3-5 business days, as each hard copy is custom printed for the organization ordering it. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.
The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.
Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.